Compound ID | 759
Synonym(s): A-40,926 | MDL 63042 | A-40926
Class: Glycopeptide
| Agent Type: | Natural product; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Neisseria gonorrhoeae, Staphylococcus aureus, Streptococcus sp., Clostridium sp., and Propionibacterium sp. |
| Description: | Natural product from Actinomadura (reclassified as Nonomuraea); teicoplanin-type; precursor of dalbavancin |
| Institute where first reported: | Biosearch Italia (Pfizer Italia) |
| Year first mentioned: | 2002 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/133082069 |
| Citations: |
|